These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 31915862

  • 1. Effects of Kappa opioid receptor blockade by LY2444296 HCl, a selective short-acting antagonist, during chronic extended access cocaine self-administration and re-exposure in rat.
    Valenza M, Windisch KA, Butelman ER, Reed B, Kreek MJ.
    Psychopharmacology (Berl); 2020 Apr; 237(4):1147-1160. PubMed ID: 31915862
    [Abstract] [Full Text] [Related]

  • 2. "Effects of the novel relatively short-acting kappa opioid receptor antagonist LY2444296 in behaviors observed after chronic extended-access cocaine self-administration in rats".
    Valenza M, Butelman ER, Kreek MJ.
    Psychopharmacology (Berl); 2017 Aug; 234(15):2219-2231. PubMed ID: 28550455
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine Dependence.
    Reed B, Butelman ER, Fry RS, Kimani R, Kreek MJ.
    Neuropsychopharmacology; 2018 Mar; 43(4):739-750. PubMed ID: 28857070
    [Abstract] [Full Text] [Related]

  • 5. Addiction-related alterations in D1 and D2 dopamine receptor behavioral responses following chronic cocaine self-administration.
    Edwards S, Whisler KN, Fuller DC, Orsulak PJ, Self DW.
    Neuropsychopharmacology; 2007 Feb; 32(2):354-66. PubMed ID: 16541082
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. LY2444296, a κ-opioid receptor antagonist, selectively reduces alcohol drinking in male and female Wistar rats with a history of alcohol dependence.
    Flores-Ramirez FJ, Illenberger JM, Pascasio G, Terenius L, Martin-Fardon R.
    Sci Rep; 2024 Mar 09; 14(1):5804. PubMed ID: 38461355
    [Abstract] [Full Text] [Related]

  • 10. Species differences in the effects of the κ-opioid receptor antagonist zyklophin.
    Sirohi S, Aldrich JV, Walker BM.
    Alcohol; 2016 Mar 09; 51():43-9. PubMed ID: 26992699
    [Abstract] [Full Text] [Related]

  • 11. Females develop features of an addiction-like phenotype sooner during withdrawal than males.
    Towers EB, Bakhti-Suroosh A, Lynch WJ.
    Psychopharmacology (Berl); 2021 Aug 09; 238(8):2213-2224. PubMed ID: 33907871
    [Abstract] [Full Text] [Related]

  • 12. Effects of cocaine place conditioning, chronic escalating-dose "binge" pattern cocaine administration and acute withdrawal on orexin/hypocretin and preprodynorphin gene expressions in lateral hypothalamus of Fischer and Sprague-Dawley rats.
    Zhou Y, Cui CL, Schlussman SD, Choi JC, Ho A, Han JS, Kreek MJ.
    Neuroscience; 2008 Jun 02; 153(4):1225-34. PubMed ID: 18436386
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of kappa opioid receptors attenuated increased cocaine intake in rats with extended access to cocaine.
    Wee S, Orio L, Ghirmai S, Cashman JR, Koob GF.
    Psychopharmacology (Berl); 2009 Sep 02; 205(4):565-75. PubMed ID: 19484223
    [Abstract] [Full Text] [Related]

  • 14. The novel dopamine D3 receptor antagonist NGB 2904 inhibits cocaine's rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats.
    Xi ZX, Newman AH, Gilbert JG, Pak AC, Peng XQ, Ashby CR, Gitajn L, Gardner EL.
    Neuropsychopharmacology; 2006 Jul 02; 31(7):1393-405. PubMed ID: 16205781
    [Abstract] [Full Text] [Related]

  • 15. The self-administration of rapidly delivered cocaine promotes increased motivation to take the drug: contributions of prior levels of operant responding and cocaine intake.
    Bouayad-Gervais K, Minogianis EA, Lévesque D, Samaha AN.
    Psychopharmacology (Berl); 2014 Oct 02; 231(21):4241-52. PubMed ID: 24752656
    [Abstract] [Full Text] [Related]

  • 16. Dissociating Motivational From Physiological Withdrawal in Alcohol Dependence: Role of Central Amygdala κ-Opioid Receptors.
    Kissler JL, Walker BM.
    Neuropsychopharmacology; 2016 Jan 02; 41(2):560-7. PubMed ID: 26105136
    [Abstract] [Full Text] [Related]

  • 17. U69593, a kappa-opioid agonist, decreases cocaine self-administration and decreases cocaine-produced drug-seeking.
    Schenk S, Partridge B, Shippenberg TS.
    Psychopharmacology (Berl); 1999 Jun 02; 144(4):339-46. PubMed ID: 10435406
    [Abstract] [Full Text] [Related]

  • 18. Two modes of intense cocaine bingeing: increased persistence after social defeat stress and increased rate of intake due to extended access conditions in rats.
    Quadros IM, Miczek KA.
    Psychopharmacology (Berl); 2009 Sep 02; 206(1):109-20. PubMed ID: 19513697
    [Abstract] [Full Text] [Related]

  • 19. MP1104, a mixed kappa-delta opioid receptor agonist has anti-cocaine properties with reduced side-effects in rats.
    Atigari DV, Uprety R, Pasternak GW, Majumdar S, Kivell BM.
    Neuropharmacology; 2019 May 15; 150():217-228. PubMed ID: 30768946
    [Abstract] [Full Text] [Related]

  • 20. Effects of the kappa-opioid receptor agonist, U69593, on the development of sensitization and on the maintenance of cocaine self-administration.
    Schenk S, Partridge B, Shippenberg TS.
    Neuropsychopharmacology; 2001 Apr 15; 24(4):441-50. PubMed ID: 11182539
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.